The genomic map of breast cancer: Which roads lead to better targeted therapies?

Justin M. Balko, Thomas P. Stricker, Carlos L. Arteaga

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Recent advances in whole-genome technologies have supplied the field of cancer research with an overwhelming amount of molecular data. Improvements in massively parallel sequencing approaches have led to logarithmic decreases in costs, and so these methods are becoming almost commonplace in the analysis of clinical trials and other cohorts of interest. Furthermore, whole-transcriptome quantification by RNA sequencing is quickly replacing microarrays. However, older chip-based methodologies such as comparative genomic hybridization and single-nucleotide polymorphism arrays have benefited from this technological explosion and are now so accessible that they can be employed in increasingly larger cohorts of patients. The study of breast cancer lends itself particularly well to these technologies. It is the most commonly diagnosed neoplasm in women, giving rise to nearly 230,000 new cases each year. Many patients are given a diagnosis of early-stage disease, for which surgery is the standard of care. These attributes result in excellent availability of tissues for whole-genome/transcriptome analysis. The Cancer Genome Atlas project has generated comprehensive catalogs of publically available genomic breast cancer data. In addition, other studies employing the power of genomic technologies in medium to large cohorts were recently published. These data are now publically available for the generation of novel hypotheses. However, these studies differed in the methods, patient cohorts, and analytical techniques employed and represent complementary snapshots of the molecular underpinnings of breast cancer. Here, we will discuss the convergences and divergences of these reports as well as the scientific and clinical implications of their findings.

Original languageEnglish (US)
Article number209
JournalBreast Cancer Research
Issue number4
StatePublished - Jul 31 2013

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'The genomic map of breast cancer: Which roads lead to better targeted therapies?'. Together they form a unique fingerprint.

Cite this